Research on LIPITOR
As the #1 prescribed branded cholesterol-lowering medication in the world, over 29 million
people in the United States have been prescribed LIPITOR.1
LIPITOR has been studied in more than 400 ongoing or completed studies. These studies
include over 80,000 patients.2
- A landmark study found that LIPITOR reduced the risk of heart attack, stroke,
certain kinds of heart surgeries, and chest pain in patients with several common
risk factors for heart disease. Risk factors include family history of early heart disease,
high blood pressure, age, low HDL ("good" cholesterol), or smoking
- Another landmark study found that LIPITOR significantly reduces the risk of
heart attack and stroke in patients with both type 2 diabetes and at least 1 other
risk factor* for heart disease
Ask your doctor today if LIPITOR is right for you.